baber/WOPTO huggingface dataset:
Patent NZ-529035-A (NZ)
Title: Chimeric skin comprised of human immortalised keratinocyte cells and human donor cells for use in skin grafting and plastic surgery methods
Inventor: ALLEN-HOFFMANN B LYNN
IPC: A61K35/12
Filed: 2002-04-24
Abstract: Disclosed is a combination of in vitro cultured conditionally immortal carrier human keratinocytes and donor patient-derived keratinocytes to form skin grafts. Such carrier keratinocytes derived from in vitro cell culture sources can be cocultured with donor patient keratinocytes using monolayer or organotypic culture methods to produce an engineered chimeric skin suitable for grafting. A conditionally immortal keratinocytes are keratinocytes that are immortal under defined growth conditions. A keratinocyte is considered immortal if it can be cultured under the defined growth conditions for more than 50 passages. The in vitro cultured conditionally immortal carrier human keratinocytes are allogeneic to the graft recipient.
Patent NZ-532088-A (NZ)
Title: Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 to be used in compositions to treat pain, cough and asthma
Inventor: TULSHIAN DEEN
IPC: A61P11/14
Filed: 2002-11-06
Abstract: Disclosed is a compound of formula I wherein: R is R4- heteroaryl or pyrimidinyl; R1 is H or C1-C6 alkyl; R2and R3 are independently selected from the group consisting of -CH3, -OCH3, fluro, chloro, bromo and iodo; R4-R7 are as defined. These compounds are useful for the treatment of cough, pain, anxiety, asthma, depression and alcohol abuse.
Patent NZ-532095-A (NZ)
Title: Systems, methods and apparatuses for manufacturing dosage forms
Inventor: SOWDEN HARRY S
IPC: A61K31/167
Filed: 2002-09-26
Abstract: Systems, methods and apparatuses for manufacturing dosage forms, and to dosage forms made using such systems, methods and apparatuses are provided. Novel compression, thermal cycle molding, and thermal setting molding modules (200) are disclosed. One or more of such modules may be linked, preferably via novel transfer device, into an overall system for making dosage forms.
Patent NZ-536745-A (NZ)
Title: Process for treatment of wood using a carrier fluid under high pressure without damaging the wood
Inventor: HENRIKSEN OLE
IPC: B27K3/08
Filed: 2003-05-08
Abstract: A process for treatment of wood susceptible to damage and having a length that is over the critical length with a fluid under high pressure is disclosed. The process is conducted in a way so that the fluid is not allowed to enter into the liquid form inside the wood. In one embodiment the process is performed in a way so the temperature during the pressurizing is not allowed to exceed the plastification temperature of the wood. In this embodiment the rate of damages of the wood is even further reduced.
Patent NZ-536803-A (NZ)
Title: Coil drain pan apparatus
Inventor: JIN CHANGJIANG
IPC: F24F1/0007
Filed: 2004-11-25
Abstract: An air conditioning cooling coil (28) and its associated drain pan (30) are 5 positionable in either a vertical or horizontal air flow orientation. With the drain pan (30)in its vertical air flow orientation, generally horizontally disposed drainage trough portions (34) of the drain pan around its periphery are sloped relative to one another in a manner such that all coil condensation received in the troughs (34) flows by gravity therethrough into a downwardly projecting condensate well (61) and outwardly through an outlet opening (62) therein. When the drain pan (30) is in its horizontal air flow orientation, the troughs (34) are disposed generally in a vertical plane, and coil condensation falls on a specially designed horizontal drip shield (36), which may be connected to the pan (30) without tools, separate fasteners or sealing material, and drains along the drip shield (36) into one of the pan troughs (34) for discharge from the main drain opening (62) of the pan (30).
Patent NZ-541589-A (NZ)
Title: Method and system for compiling and managing electronic surveys
Inventor: MILL ANARU ROBERT
Filed: 2005-08-01
Abstract: A method of managing an electronic survey over a computer network and by use of computers at a server and a survey responder node is disclosed. The method includes creating a survey scenario by defining questions and attributing identifications to each of the possible responses. The survey includes at least one survey scenario. The survey scenario is presented to a survey responder at a node in the network and a response data to the survey is and obtained. The survey response data is checked to ensure it complies with survey rules, and when the response data is correct and complete the survey response data is transferred to the server. The survey response data is then converted to mapped entity objects or elements suitable for storing in fields in a relational database. Datasets based on the survey response data stored in the database are queried and retrieved. The response data is manipulated and recompiled to form reports.
Patent NZ-543528-A (NZ)
Title: Bottle cap and method therefor
Inventor: REED DAVID F
Filed: 2005-11-14
Abstract: A closure assembly includes an inner cap with threading along an inner surface. A threading profile extends along an outer surface of an inner cap sidewall. An outer cap is coupled with the inner cap. The outer cap includes an outer cap sidewall extending along at least a portion of the inner cap sidewall, and the outer cap sidewall is substantially cylindrical and uniformly smooth along at least an exterior face. The outer cap sidewall is sized and shaped to conceal the threading profile. An annular rim of the outer cap extends from an open end of the outer cap, and the annular rim is inwardly bent toward the inner cap. In another example, the annular rim extends over the inner cap sidewall and couples the outer cap with the inner cap with an interference fit.
Patent NZ-561819-A (NZ)
Title: Dietary fiber composition comprising glucomannan, xanthan gum, and alginate
Inventor: GAHLER ROLAND J
IPC: A23L21/10
Filed: 2006-04-10
Abstract: Provided is a granulated dietary fiber composition comprising from about 48% to about 90% (w/w) glucomannan, from about 5% to about 20% (w/w) xanthan gum, and from about 5% to about 30% (w/w) alginate. Further provided is a food product comprising the composition and use of the composition in a method cosmetic method for promoting satiety and/or promoting weight loss, in a mammal, comprising administering to a mammal an amount of a granulated dietary fiber composition effective to promote satiety and/or to promote weight loss.
Patent NZ-577587-A (NZ)
Title: A tapping saddle pipe fitting with visual seal indicator at least flush with fitting surface
Inventor: BAIER WARREN ARTHUR
IPC: F16B7/08
Filed: 2009-06-09
Abstract: Disclosed is a saddle fitting for tapping into a primary pipe to provide flow from the primary pipe to a secondary pipe. The saddle fitting comprises: two parts (110, 120) adapted to be pivotally coupled at matching ends to enable the parts to clamp about the primary pipe; an aperture (160) through one of the parts for receiving a member to communicate flow from the primary pipe to the secondary pipe; and a sealing element for sealing between an interior surface of the part having the aperture and an exterior surface of the primary pipe. The sealing element has at least one sealing indicator (152a, 152b) extending from the sealing clement such that an end of the indicator lies at least flush with an exterior surface (110b) of the fitting.
Patent NZ-580890-A (NZ)
Title: Integrated mask and prongs for nasal CPAP
Inventor: HAN STEVE
IPC: A61M16/06
Filed: 2008-05-27
Abstract: An integrated nasal mask adapted for delivering gas to a patient comprises a mask body defining a nasal cavity; an interface portion coupled with the mask body with the interface portion comprising at least one patient port and at least one elongate hollow nostril-engaging stem extending outwardly from the nasal cavity and defining a fluid passageway for delivering gas to a nose of the patient. The elongate hollow nostril-engaging stem is fluidly coupled with the patient port of the interface portion. The interface portion is configured to couple with a universal interface and the universal interface comprises a supply passageway, a pressure passageway and an exhalation port. The elongate hollow nostril- engaging stem is configured to physically secure inside the patient nose thereby securing the nasal mask without requiring a head strap.
Patent NZ-589555-A (NZ)
Title: Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
Inventor: BOTTON GERARD
IPC: C07D405/04
Filed: 2009-03-31
Abstract: A compound of the general formula (I) wherein: R1 is selected from ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, hexyl, octyl, decanyl, dodecanyl, hexadecyl, octadecyl, ethenyl, 2-propenyl, 2-butenyl, 3-butenyl, 2-pentenyl, 3-pentenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heterocycloalkyl, alkoxyalkyl; R2 and R3 is selected from hydrogen, alkyl, cycloalkyl; A is selected from aryl, heteroaryl, arylalkyl, wherein alkyl, aryl and heteroaryl groups can be optionally substituted by one or more substituents selected from Y; Y is: hydroxy, thio, halogen, cyano, trifluoromethoxy, trifluoromethyl, carboxy, carboxymethyl, carboxyethyl, alkyl, alkoxy, alkylamino, aryl, aryl sulfonylalkyl, aryloxy, arylalkoxy, amino, NR5R6, azido, nitro, guanidino, amidino, phosphono, oxo, carbamoyle, alkylsulfonyl, alkylsulfinyl, alkylthio, SF5 , or two Y groups can form a methylenedioxy; R5 and R6 are as disclosed in the specification and can be optionally substituted by one or more substituents selected from Y, or R5 and R6 together can constitute a heterocycle; R2 and R3 can constitute a cycle wherein: R1 and A are defined as above; the number of ring members is 3, 4,5; the ring is substituted with one or more substituents selected from hydrogen, alkyl and others as disclosed in the specification. Also disclosed is the application of these compounds to the treatment of hyperglycemia and similar or associated conditions i.e. diabetes.
Patent NZ-590553-A (NZ)
Title: Post-impregnation treatments to improve distribution of metal biocides in an impregnated substrate
Inventor: HAYSON KIMBERLY S
IPC: A01N59/20
Filed: 2009-03-12
Abstract: Disclosed is a method of treating biodegradable material with a metal biocide, such as wood or other starch based products, to prevent attack by insects, fungi or microbes. The method involves: a) providing the biodegradable substrate, said substrate comprising (i) a first substrate region distal from a surface of the substrate, said first substrate region having a first concentration of a metal biocide; and (ii) a second substrate region proximal to the surface of the substrate, said second substrate region having a second concentration of metal biocide that is reduced relative to the first substrate region; and b) contacting the surface of the substrate with an aqueous, fluid composition comprising a complexing agent capable of forming a water-soluble metal complex with the metal biocide, said complexing agent and metal biocide having a complex stability constant K1 in the range of from about 2.5 to about 6.5, said contact causing a portion of the metal biocide in the first substrate region to be redistributed to the second substrate region.
Patent NZ-591458-A (NZ)
Title: Novel single unit carbapenem aminoglycoside formulations the aminoglycoside is etimicin
Inventor: CHAUDHARY MANU
IPC: A61K31/7036
Filed: 2009-09-15
Abstract: Disclosed is a pharmaceutical formulation for reduction in drug and disease induced toxicities achieved by reducing dose, said pharmaceutical formulation comprising: two different group of antibiotics as active constituents present as synergistic fixed dose combination in parenteral dosage form with bactericidal efficacy, wherein a first antibiotic is a carbapenem or a pharmaceutically acceptable salts thereof; wherein a second antibiotic is an aminoglycoside which is etimicin or a pharmaceutically acceptable salts thereof; and wherein said first antibiotic and said second antibiotics are present in weight ratios of 6:1 to 13:1; wherein said pharmaceutical formulation comprises one or more of additive selected from a group of synthetic/ natural amino acids/ vitamins/ stabilizers/ polymers/ antioxidants/ micronutrients. The composition preferably also includes EDTA.
Patent NZ-596608-A (NZ)
Title: New potent anti apob antisense compounds
Inventor: NIELSEN NIELS FISKER
IPC: A61K31/713
Filed: 2010-06-14
Abstract: 596608 Discloses a single stranded oligomer having a length between 12 to 30 nucleotides and comprising the nucleotide sequence 3’ – GTTGACACTGTC- 5’, which is capable of down-regulating expression of apoliprotein-B100 (APO-B100).
Patent NZ-597815-A (NZ)
Title: Milking robot arm with an imaging means which can tilt to image both hind legs and teats
Inventor: KRUKOWSKI MARILYN
IPC: A01J5/017
Filed: 2010-08-19
Abstract: Disclosed is a milking robot for teat cup attachment. The milking robot is comprised of a robot arm having a gripper for holding at least one teat cup at a time, an image recording device mounted on the robot arm and provided to record at least one image of the teats of a milking animal and a control device. The control device is provided to control the robot arm to position the teat cup at a teat of the milking animal based on the at least one image of the teats of the milking animal. The image recording device is provided to record at least one image of the hind legs of the milking animal before recording the at least one image of the teats of the milking animal. The control device is provided to, before controlling the robot arm to attach the teat cup to the teat of the milking animal, control the robot arm to move the teat cup between the hind legs of the milking animal from the rear of the milking animal and towards the udder based on the at least one image of the hind legs of the milking animal. The milking robot comprises means for pivoting the image recording device with respect to the gripper of the robot arm between the recording of the at least one image of the hind legs of the milking animal and the recording of the at least one image of the teats of the milking animal.
Patent NZ-599095-A (NZ)
Title: Transferring electric energy to a vehicle, using a system which comprises consecutive segments for energy transfer
Inventor: ZENGERLE MANFRED
IPC: B60M3/04
Filed: 2010-10-26
Abstract: 599095 Disclosed is a system for transferring electric energy to a vehicle (214), in particular to a track bound vehicle such as a light rail vehicle. The system includes an electric conductor arrangement for producing an alternating electromagnetic field and for thereby transferring the energy to the vehicle (214). The conductor arrangement includes a plurality of consecutive segments (211), such that the segments (211) extend along a path of travel of the vehicle (214). The system also includes a direct current supply for conducting electric energy to the segments (211) and includes a first and a second direct current line (213a, 213b). The first direct current line (213a) is operated at a different electric potential than the second direct current line (213b). A plurality of inverters (C) is provided, wherein each of the inverters (C) is connected to the direct current supply such that an alternating current which is necessary for producing the alternating electromagnetic field in a respective segment is generated by one of the inverters (C) or by respective inverters (C). Each segment (211) is connected to the direct current supply via at least one of the inverters (C) which is adapted to invert a direct current carried by the direct current supply to the alternating current carried by the respective segment (211). The system further includes a modulation device for modulating the electric potential of at least one of the first and second direct current line (213a, 213b) using a predetermined modulation frequency, thereby producing a direct voltage having an overlaid voltage alternating with the modulation frequency. At least one of the inverters (C) comprises a transformer having a primary and a secondary winding. The primary winding is connected to the first or second direct current line (213a, 213b), so that the direct current flows through the primary winding and the secondary winding is connected to a power supply arrangement adapted to provide electric energy for operating the inverter (C).
Patent NZ-599693-A (NZ)
Title: Swing gate
Inventor: EVANS EDWARD
IPC: E06B11/02
Filed: 2010-10-11
Abstract: 599693 A gate 30 for a stock yard or race is provided with an end flap 46 which pivots either way on hinges 42 from the main gate portion 44. If a beast 24 charges the gate so pivoting the gate toward the stockman about the main gate hinge 40, the end flap 46 can pivot away from the stockman 22 who is trying to fasten the gate to the yard post.
Patent NZ-623764-A (NZ)
Title: A sea vessel with a stabilised platform for a hydrocarbon processing system
Inventor: YEMINGTON CHARLES R
IPC: B63B39/00
Filed: 2010-07-14
Abstract: A small sea vessel subject to high vessel motion of heave, pitch and roll has a stabilised frame (40) on which a hydrocarbon processing system is held. The stabilisation system consists of paired cylinders (52F, 52A; 53S, 53P) to maintain the frame (40) essentially level. Each cylinder (52F, 52A, 53S, 53P) is mounted on the vessel’s deck (31) and each cylinder rod extends upward to a compliant connection (51) to support the frame (40). Each pair of cylinders (52F, 52A; 53S, 53P) has a hydraulic control system consisting of a fluid line between load bearing chambers and a second line between non-load bearing chambers of the cylinders (52F, 52A, 53S, 53P).
Patent NZ-625770-A (NZ)
Title: Method of fracturing using ultra lightweight proppant suspensions and gaseous streams
Inventor: WHEELER RICHARD S
IPC: C09K8/80
Filed: 2013-02-04
Abstract: A method of fracturing a subterranean formation comprises introducing a proppant stage into the subterranean formation. The proppant stage comprises a fine textured foam contains (i) a viscosified aqueous fluid having ultra lightweight (ULW) proppant of apparent specific gravity less than or equal to 2.45 suspended in the viscosified aqueous fluid; and (ii) a gaseous fluid. The gaseous fluid constitutes at least about 85 volume percent of the combination of gaseous fluid and aqueous fluid in the fine textured foam. The diameter of at least 70% gas volume of the bubbles of the fine textured foam is less than or equal to 0.18 mm and further the proppant stage is introduced into the subterranean formation at a pressure sufficient to create or enlarge a fracture.
Patent NZ-630170-A (NZ)
Title: Tetrahydro-quinazolinone derivatives as tank and parp inhibitors
Inventor: BUCHSTALLER HANS-PETER
IPC: C07D403/12
Filed: 2013-01-14
Abstract: Disclosed are selected tetrahydro-quinazolin-4-one compounds encompassed by the formula I. The compounds are inhibitors of Tankyrase, and are intended for use in the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation. Examples of the compounds include: 2-[4-(3-fluorophenyl)piperazin-1-yl]-5,6,7,8-tetrahydro-3H-quinazolin-4-one and N-pyridin-2-yl-2-[4-(4-oxo-3,4,5,6,7,8-hexahydroquinazolin-2-yl)piperazin-1-yl]acetamide.
Patent NZ-715352-A (NZ)
Title: Injection device
Inventor: JENNINGS DOUGLAS IVAN
IPC: A61M5/20
Filed: 2014-06-11
Abstract: An injection device comprises an actuator adapted when actuated to cause commencement of an injection sequence; a locking mechanism adapted to be moved between a locked position in which the locking mechanism prevents the actuator from being actuated, and an unlocked position in which the actuator can be actuated to cause commencement of the injection sequence. The locking mechanism comprises a contact portion which in the locked position of the locking mechanism projects against the actuator. The contact portion comprises a curved surface. Existing injection devices have exhibited problems with users being unable to actuate the trigger correctly. The injection device of the present invention overcomes this problem.
Patent NZ-727613-A (NZ)
Title: Panel and method of forming same
Inventor: KYRIAKOULEAS LOUIE
IPC: B32B9/00
Filed: 2013-08-30
Abstract: Disclosed is a stone veneer replica panel to provide the look and feel of a natural product but with a reduced lightweight mass. The panel (10) includes a surface sheet formed from a first material adhered to a less dense body layer. The surface sheet comprises a sheet cut from natural stone such as granite, marble quartz. The body layer is thicker than the surface sheet and is made of a voided material such as foam or honeycomb. The panel (10) further includes a side edge portion (16) of the same material as the surface sheet adhered along the entire edge perimeter to hide the base layer from view.
Patent NZ-730821-A (NZ)
Title: Stable protein solution formulation containing high concentration of an anti-vegf antibody
Inventor: ZHANG HUIXIANG
IPC: A61P27/02
Filed: 2015-11-06
Abstract: The present invention provides anti-VEGF antibodies formulated as high concentration, aqueous pharmaceutical compositions, suitable for an injection, preferably an intravitreal injection. The aqueous pharmaceutical compositions are useful for delivery of a high concentration of the antibody active ingredient to a patient without high levels of antibody aggregation and without a high level of sub-visible particulate matter. An aqueous composition of the invention comprises an antibody having a concentration of at least 50 mg/ml. An aqueous ophthalmic pharmaceutical composition of the invention includes sucrose as a sugar, a citrate buffer, polysorbate 80 as a surfactant, wherein the pH of the composition is about 6.3 to about 7.3, and wherein the maximum number of particles ≥ 10 μm in said composition is 50 per mL.
Patent NZ-741225-A (NZ)
Title: Use of neuregulin to treat peripheral nerve injury
Inventor: CAGGIANO ANTHONY
IPC: A61P25/02
Filed: 2013-03-29
Abstract: In one embodiment the present invention relates to a use of a polypeptide comprising an EGF-like domain of glial growth factor 2 (GGF2) in the manufacture of a medicament for prophylactically reducing neuropathic pain in a subject at risk of incurring a peripheral nerve injury due to a surgical procedure. In another embodiment the invention relates to a use of a polypeptide comprising an EGF-like domain of glial growth factor 2 (GGF2) in the manufacture of a medicament for reducing neuropathic pain in a subject having an existing peripheral nerve injury due to a surgical procedure. In a further embodiment the invention relates to a use of a polypeptide comprising an EGF-like domain of glial growth factor 2 (GGF2) in the manufacture of a medicament to decrease neuropathic pain in a subject having an existing sciatic nerve injury due to a surgical procedure. In yet another embodiment the invention provides a use of a polypeptide comprising an EGF-like domain of glial growth factor 2 (GGF2) in the manufacture of a medicament for reducing neuropathic pain in a subject in the course of incurring a peripheral nerve injury during a surgical procedure.